Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis.

van Heemst J, Jansen DT, Polydorides S, Moustakas AK, Bax M, Feitsma AL, Bontrop-Elferink DG, Baarse M, van der Woude D, Wolbink GJ, Rispens T, Koning F, de Vries RR, Papadopoulos GK, Archontis G, Huizinga TW, Toes RE.

Nat Commun. 2015 May 5;6:6681. doi: 10.1038/ncomms7681.

PMID:
25942574
2.

Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy.

Nieuwenhuijzen JA, de Vries RR, van Tinteren H, Bex A, Van der Poel HG, Meinhardt W, Horenblas S.

Eur J Surg Oncol. 2014 Dec;40(12):1677-85. doi: 10.1016/j.ejso.2013.12.017. Epub 2014 Jan 2.

PMID:
24462548
3.

Prostate sparing cystectomy for bladder cancer: 20-year single center experience.

Mertens LS, Meijer RP, de Vries RR, Nieuwenhuijzen JA, van der Poel HG, Bex A, van Rhijn BW, Meinhardt W, Horenblas S.

J Urol. 2014 May;191(5):1250-5. doi: 10.1016/j.juro.2013.11.031. Epub 2013 Nov 25.

PMID:
24286830
4.

Short-term outcome after cystectomy: comparison of two different perioperative protocols.

de Vries RR, Kauer P, van Tinteren H, van der Poel HG, Bex A, Meinhardt W, van Haarst EP, Horenblas S.

Urol Int. 2012;88(4):383-9. doi: 10.1159/000336155. Epub 2012 Mar 14.

PMID:
22433508
5.

The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigens.

Willemze A, van der Woude D, Ghidey W, Levarht EW, Stoeken-Rijsbergen G, Verduyn W, de Vries RR, Houwing-Duistermaat JJ, Huizinga TW, Trouw LA, Toes RE.

Arthritis Rheum. 2011 Jul;63(7):1823-32. doi: 10.1002/art.30409.

6.

[Pregnancy following sexuality-preserving cystectomy for bladder carcinoma].

Nunnink CJ, de Vries RR, Meinhardt W, van der Poel HG, Bex A, Horenblas S.

Ned Tijdschr Geneeskd. 2011;155:A2820. Dutch.

PMID:
21447217
7.

Genetics of ACPA-positive rheumatoid arthritis: the beginning of the end?

de Vries RR, van der Woude D, Houwing JJ, Toes RE.

Ann Rheum Dis. 2011 Mar;70 Suppl 1:i51-4. doi: 10.1136/ard.2010.138040. Review.

PMID:
21339219
8.

Haemovigilance: an effective tool for improving transfusion practice.

de Vries RR, Faber JC, Strengers PF; Board of the International Haemovigilance Network.

Vox Sang. 2011 Jan;100(1):60-7. doi: 10.1111/j.1423-0410.2010.01442.x. Review.

PMID:
21175656
9.

Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis.

van der Woude D, Alemayehu WG, Verduijn W, de Vries RR, Houwing-Duistermaat JJ, Huizinga TW, Toes RE.

Nat Genet. 2010 Oct;42(10):814-6; author reply 816. doi: 10.1038/ng1010-814. No abstract available.

PMID:
20877316
10.

Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.

van der Woude D, Lie BA, Lundström E, Balsa A, Feitsma AL, Houwing-Duistermaat JJ, Verduijn W, Nordang GB, Alfredsson L, Klareskog L, Pascual-Salcedo D, Gonzalez-Gay MA, Lopez-Nevot MA, Valero F, Roep BO, Huizinga TW, Kvien TK, Martín J, Padyukov L, de Vries RR, Toes RE.

Arthritis Rheum. 2010 May;62(5):1236-45. doi: 10.1002/art.27366.

11.

Outcome of treatment of bladder cancer: a comparison between low-volume hospitals and an oncology centre.

de Vries RR, Visser O, Nieuwenhuijzen JA, Horenblas S; Members of the Urological Oncology Working Group of the Comprehensive Cancer Centre Amsterdam.

World J Urol. 2010 Aug;28(4):431-7. doi: 10.1007/s00345-010-0512-z. Epub 2010 Feb 4.

PMID:
20130885
12.

Survival after cystectomy for invasive bladder cancer.

de Vries RR, Nieuwenhuijzen JA, Vincent A, van Tinteren H, Horenblas S.

Eur J Surg Oncol. 2010 Mar;36(3):292-7. doi: 10.1016/j.ejso.2009.11.012. Epub 2010 Jan 25.

PMID:
20097512
13.

Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.

Feitsma AL, van der Voort EI, Franken KL, el Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A.

Arthritis Rheum. 2010 Jan;62(1):117-25. doi: 10.1002/art.25059.

14.

Underreporting of major obstetric haemorrhage in the Netherlands.

Zwart JJ, Yazdani ST, Harvey MS, de Vries RR, van Roosmalen J.

Transfus Med. 2010 Apr;20(2):118-22. doi: 10.1111/j.1365-3148.2009.00967.x. Epub 2009 Aug 25.

PMID:
19708894
15.

Prostate-sparing cystectomy: long-term oncological results.

de Vries RR, Nieuwenhuijzen JA, van Tinteren H, Oddens JR, Visser O, van der Poel HG, Bex A, Meinhardt W, Horenblas S; Urological Working Group of the Amsterdam Comprehensive Cancer Center.

BJU Int. 2009 Nov;104(9):1239-43. doi: 10.1111/j.1464-410X.2009.08615.x. Epub 2009 Jun 22.

16.

Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.

van der Woude D, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Thomson W, Worthington J, van der Helm-van Mil AH, de Vries RR.

Arthritis Rheum. 2009 Apr;60(4):916-23. doi: 10.1002/art.24385.

17.

Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients.

Schonewille H, de Vries RR, Brand A.

Transfusion. 2009 Mar;49(3):453-7. doi: 10.1111/j.1537-2995.2008.01980.x.

PMID:
19243541
18.

Protection against rheumatoid arthritis by HLA: nature and nurture.

Feitsma AL, van der Helm-van Mil AH, Huizinga TW, de Vries RR, Toes RE.

Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii61-3. doi: 10.1136/ard.2008.098509. Review.

PMID:
19022816
19.

Tic-tac-toe does not provide lessons for appreciating the HLA-rheumatoid arthritis relationship: comment on the editorial by Bridges et al.

van der Helm-van Mil AH, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2008 Nov;58(11):3635; author reply 3635-6. doi: 10.1002/art.24033. No abstract available.

20.

Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.

de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.

Eur J Surg Oncol. 2009 Apr;35(4):352-5. doi: 10.1016/j.ejso.2008.07.001. Epub 2008 Aug 22.

PMID:
18722076
21.

Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.

de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.

Arthritis Rheum. 2008 May;58(5):1293-8. doi: 10.1002/art.23439.

22.

Reduced frequency of blood group Lewis a-b- in female Type 1 diabetes patients.

Kharagjitsingh AV, Prinsen K, Lemkes HH, de Vries RR, Roep BO, Buschard K.

Diabet Med. 2008 Feb;25(2):236-8. doi: 10.1111/j.1464-5491.2007.02340.x. Epub 2008 Jan 21.

PMID:
18215173
23.

Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development.

Feitsma AL, Worthington J, van der Helm-van Mil AH, Plant D, Thomson W, Ursum J, van Schaardenburg D, van der Horst-Bruinsma IE, van Rood JJ, Huizinga TW, Toes RE, de Vries RR.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19966-70. Epub 2007 Dec 6.

24.

Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.

Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AH, de Vries-Bouwstra JK, Allaart CF, Drijfhout JW, de Vries RR, Breedveld FC, Huizinga TW, Pruijn GJ, Toes RE.

Arthritis Rheum. 2007 Dec;56(12):3949-52.

25.

Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions.

Nieuwenhuijzen JA, de Vries RR, Bex A, van der Poel HG, Meinhardt W, Antonini N, Horenblas S.

Eur Urol. 2008 Apr;53(4):834-42; discussion 842-4. Epub 2007 Sep 18.

PMID:
17904276
26.

Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles.

Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, Jol-van der Zijde CM, van Tol MJ, Drijfhout JW, Breedveld FC, de Vries RR, Huizinga TW, Toes RE.

Arthritis Rheum. 2007 Sep;56(9):2913-8.

27.

Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures.

Lamboo M, Poland DC, Eikenboom JC, Harvey MS, Groot E, Brand A, de Vries RR.

Transfus Med. 2007 Jun;17(3):182-6.

PMID:
17561859
28.

Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis.

van der Helm-van Mil AH, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2007 Jun;56(6):1728-35. Review. No abstract available.

29.

Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.

Feitsma AL, Toes RE, Begovich AB, Chokkalingam AP, de Vries RR, Huizinga TW, van der Helm-van Mil AH.

Rheumatology (Oxford). 2007 Jul;46(7):1092-5. Epub 2007 Mar 6.

PMID:
17341507
30.
31.

The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.

van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2007 Feb;56(2):425-32.

32.

A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma.

Kerkhoffs JL, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ, Brand A.

Blood. 2006 Nov 1;108(9):3210-5. Epub 2006 Jul 6.

PMID:
16825492
33.

HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMA.

de Vries RR, Huizinga TW, Toes RE.

Hum Immunol. 2006 Jun;67(6):454-9. Epub 2006 Apr 3. Review.

PMID:
16728269
34.
35.

Redefining the HLA and RA association: to be or not to be anti-CCP positive.

de Vries RR, Huizinga TW, Toes RE.

J Autoimmun. 2005;25 Suppl:21-5. Epub 2005 Oct 27. Review.

PMID:
16257178
36.

Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.

Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA.

Arthritis Rheum. 2005 Nov;52(11):3433-8.

37.

Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.

Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2005 Oct;52(10):3058-62.

38.

An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility.

van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE.

Arthritis Rheum. 2005 Sep;52(9):2637-44.

39.

Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, Breedveld FC, Toes RE, Huizinga TW.

Ann Rheum Dis. 2006 Mar;65(3):366-71. Epub 2005 Jul 13.

40.

Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells.

Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM, de Vries RR, Toes RE.

Arthritis Rheum. 2005 Jul;52(7):2212-21.

41.

Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.

Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, Elferink BG, van der Zanden L, de Vries RR, Huizinga TW, Ottenhoff TH, Toes RE.

Hum Immunol. 2005 Jan;66(1):13-20.

PMID:
15620457
42.

Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation.

Flierman R, Witteveen HJ, van der Voort EI, Huizinga TW, de Vries RR, Fibbe WE, Toes RE, van Laar JM.

Blood. 2005 Apr 1;105(7):2991-4. Epub 2004 Dec 16.

PMID:
15604221
43.

Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis.

van Bilsen JH, van Dongen H, Lard LR, van der Voort EI, Elferink DG, Bakker AM, Miltenburg AM, Huizinga TW, de Vries RR, Toes RE.

Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17180-5. Epub 2004 Nov 29.

44.

CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.

Morgan ME, Witteveen HJ, Sutmuller RP, de Vries RR, Toes RE.

Hum Immunol. 2004 Nov;65(11):1319-27.

PMID:
15556682
45.

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE, de Vries RR.

Arthritis Rheum. 2004 Jul;50(7):2113-21.

46.

HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65.

Tree TI, Duinkerken G, Willemen S, de Vries RR, Roep BO.

Diabetes. 2004 Jul;53(7):1692-9.

47.

Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease.

Koeleman BP, Lie BA, Undlien DE, Dudbridge F, Thorsby E, de Vries RR, Cucca F, Roep BO, Giphart MJ, Todd JA.

Genes Immun. 2004 Aug;5(5):381-8.

PMID:
15164102
48.

Moyamoya and extracranial vascular involvement: fibromuscular dysplasia? A report of two children.

de Vries RR, Nikkels PG, van der Laag J, Broere G, Braun KP.

Neuropediatrics. 2003 Dec;34(6):318-21.

PMID:
14681758
49.

Interferon-gamma production in response to M. tuberculosis antigens in TB patients in Indonesia.

Subronto YW, van Meijgaarden KE, Geluk A, Arend SM, Sunardi T, Franken KL, Hisyam B, de Vries RR, Ottenhoff TH.

Adv Exp Med Biol. 2003;531:249-60. No abstract available.

PMID:
12916797
50.

CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.

Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, Melief CJ, Snijders A, Offringa R, de Vries RR, Toes RE.

Arthritis Rheum. 2003 May;48(5):1452-60.

Supplemental Content

Loading ...
Support Center